{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:11:28Z","timestamp":1772752288056,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0724-1","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T12:05:24Z","timestamp":1507118724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression"],"prefix":"10.1186","volume":"18","author":[{"given":"Lingyu","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"issue":"2","key":"724_CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2010.06.093","volume":"398","author":"T Matsui","year":"2010","unstructured":"Matsui T, Yamagishi S, Takeuchi M, Ueda S, Fukami K, Okuda S. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun. 2010;398(2):326\u201330.","journal-title":"Biochem Biophys Res Commun"},{"key":"724_CR2","first-page":"797548","volume":"2013","author":"LL Kong","year":"2013","unstructured":"Kong LL, Wu H, Cui WP, Zhou WH, Luo P, Sun J, Yuan H, Miao LN. Advances in murine models of diabetic nephropathy. J Diabetes Res. 2013;2013:797548.","journal-title":"J Diabetes Res"},{"issue":"4","key":"724_CR3","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","volume":"63","author":"WF Keane","year":"2003","unstructured":"Keane WF, Brenner BM, De Zeeuw D, Grunfeld J-P, Mcgill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003;63(4):1499\u2013507.","journal-title":"Kidney Int"},{"issue":"8","key":"724_CR4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpendmet0894","volume":"4","author":"S Dronavalli","year":"2008","unstructured":"Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab. 2008;4(8):444\u201352.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"7","key":"724_CR5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/diabetes.53.7.1831","volume":"53","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes. 2004;53(7):1831\u201340.","journal-title":"Diabetes"},{"issue":"2","key":"724_CR6","first-page":"168","volume":"16","author":"S Salchell","year":"2003","unstructured":"Salchell S, Mathieson PW. Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology. J Nephrol. 2003;16(2):168\u201378.","journal-title":"J Nephrol"},{"key":"724_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000325649","volume":"170","author":"KN Lai","year":"2011","unstructured":"Lai KN, Leung JC, Tang SC. The renin-angiotensin system. Contrib Nephrol. 2011;170:135\u201344.","journal-title":"Contrib Nephrol"},{"issue":"1","key":"724_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, Chugh SS. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med. 2011;17(1):117\u201322.","journal-title":"Nat Med"},{"issue":"1","key":"724_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nm0111-44","volume":"17","author":"J Reiser","year":"2011","unstructured":"Reiser J. Filtering new facts about kidney disease. Nat Med. 2011;17(1):44\u20135.","journal-title":"Nat Med"},{"issue":"2","key":"724_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","volume":"59","author":"SS Chugh","year":"2012","unstructured":"Chugh SS, Clement LC, Mac\u00e9 C. New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis. 2012;59(2):284\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"724_CR11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jep.2013.11.028","volume":"151","author":"X Liu","year":"2014","unstructured":"Liu X, Liu L, Chen P, Zhou L, Zhang Y, Wu Y, Jiang L, Cheng D, Huang W, Yi D. Clinical trials of traditional Chinese medicine in the treatment of diabetic nephropathy\u2014A systematic review based on a subgroup analysis. J Ethnopharmacol. 2014;151(2):810\u20139.","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"724_CR12","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s001250100000","volume":"44","author":"ME Cooper","year":"2001","unstructured":"Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia. 2001;44(11):1957\u201372.","journal-title":"Diabetologia"},{"issue":"4","key":"724_CR13","doi-asserted-by":"crossref","first-page":"F1083","DOI":"10.1152\/ajprenal.00401.2006","volume":"293","author":"J Allard","year":"2007","unstructured":"Allard J, Buleon M, Cellier E, Renaud I, Pecher C, Praddaude F, Conti M, Tack I, Girolami JP. ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats. Am J Physiol Renal Physiol. 2007;293(4):F1083\u201392.","journal-title":"Am J Physiol Renal Physiol"},{"key":"724_CR14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.saa.2014.04.024","volume":"130","author":"IA Naguib","year":"2014","unstructured":"Naguib IA, Abdelaleem EA, Draz ME, Zaazaa HE. Linear support vector regression and partial least squares chemometric models for determination of Hydrochlorothiazide and Benazepril hydrochloride in presence of related impurities: a comparative study. Spectrochim Acta A Mol Biomol Spectrosc. 2014;130:350\u20136.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"724_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1075-6280(02)29002-3","volume":"29","author":"HG Brittain","year":"2002","unstructured":"Brittain HG. Profiles of Drug Substances, Excipients, and Related Methodology. Analy Profiles Drug Subst Excipients. 2002;29:1\u20135.","journal-title":"Analy Profiles Drug Subst Excipients"},{"key":"724_CR16","first-page":"967","volume":"16","author":"RA Gismondi","year":"2015","unstructured":"Gismondi RA, Oigman W, Bedirian R, Pozzobon CR, Ladeira MC, Neves MF. Comparison of benazepril and losartan on endothelial function and vascular stiffness in patients with Type 2 diabetes mellitus and hypertension: A randomized controlled trial. JRAAS. 2015;16:967.","journal-title":"JRAAS"},{"key":"724_CR17","first-page":"321","volume":"34","author":"B Zhi-hui","year":"2012","unstructured":"Zhi-hui B, Zhen M. Combination Therapy of Benazepril Hydrochloride with Hydrochlor-othiazide for Renal Hypertension. Guide China Med. 2012;34:321.","journal-title":"Guide China Med"},{"issue":"6","key":"724_CR18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3892\/etm.2013.1335","volume":"6","author":"W Wang","year":"2013","unstructured":"Wang W, Li L, Zhou Z, Gao J, Sun Y. Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and\/or angiotensin II receptor blockers on chronic glomerular disease. Exp Ther Med. 2013;6(6):1527\u201331.","journal-title":"Exp Ther Med"},{"issue":"1","key":"724_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","volume":"20","author":"LC Clement","year":"2014","unstructured":"Clement LC, Mace C, Avila-Casado C, Joles JA, Kersten S, Chugh SS. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med. 2014;20(1):37\u201346.","journal-title":"Nat Med"},{"key":"724_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2014.00023","volume":"5","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Mace C, Clement LC, Del Nogal AM, Marshall CB. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol. 2014;5:23.","journal-title":"Front Pharmacol"},{"issue":"8","key":"724_CR21","doi-asserted-by":"crossref","first-page":"e106164","DOI":"10.1371\/journal.pone.0106164","volume":"9","author":"L Peng","year":"2014","unstructured":"Peng L, Ma J, Cui R, Chen X, Wei SY, Wei QJ, Li B. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. PLoS One. 2014;9(8):e106164.","journal-title":"PLoS One"},{"issue":"2","key":"724_CR22","doi-asserted-by":"crossref","first-page":"F243","DOI":"10.1152\/ajprenal.00300.2002","volume":"284","author":"HW Schnaper","year":"2003","unstructured":"Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 2003;284(2):F243\u201352.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"724_CR23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s001250051515","volume":"43","author":"A Flyvbjerg","year":"2000","unstructured":"Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia. 2000;43(10):1205\u201323.","journal-title":"Diabetologia"},{"issue":"4","key":"724_CR24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s13105-012-0169-8","volume":"68","author":"P Quintero","year":"2012","unstructured":"Quintero P, Gonz\u00e1lez-Muniesa P, Garcia-Diaz DF, Mart\u00ednez JA. Effects of hyperoxia exposure on metabolic markers and gene expression in 3T3-L1 adipocytes. J Physiol Biochem. 2012;68(4):663\u20139.","journal-title":"J Physiol Biochem"},{"issue":"12","key":"724_CR25","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1253\/circj.CJ-09-0710","volume":"73","author":"Y Oike","year":"2009","unstructured":"Oike Y, Tabata M. Angiopoietin-Like Proteins Potential Therapeutic Targets for Metabolic Syndrome and Cardiovascular Disease. Circ J. 2009;73(12):2192\u20137.","journal-title":"Circ J"},{"key":"724_CR26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1479164113496441","volume":"10","author":"DC Musial","year":"2013","unstructured":"Musial DC, da Silva J\u00fanior ED, da Silva RM, Miranda-Ferreira R, Lima-Landman MTR, Jurkiewicz A, Garc\u00eda AG, Jurkiewicz NH. Increase of angiotensin-converting enzyme activity and peripheral sympathetic dysfunction could contribute to hypertension development in streptozotocin-induced diabetic rats. Diab Vasc Dis Res. 2013;10:498. 1479164113496441","journal-title":"Diab Vasc Dis Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0724-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T12:05:29Z","timestamp":1507118729000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0724-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0724-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"article-number":"307"}}